Fahad Drug Targeting
Transcript of Fahad Drug Targeting
-
7/31/2019 Fahad Drug Targeting
1/24
A PRESENTATIONON
DRUG TARGETING
PresenterFahad Hussain
Roll: ASH 1003MS 113MM. Pharm, Department of Pharmacy
Noakhali Science and Technology University
1
-
7/31/2019 Fahad Drug Targeting
2/24
DRUG TARGETING
BackgroundProblems associated with Systemic Drug Administration
Even bio-distribution of pharmaceuticals throughout the
body
The lack of drug specific affinity toward a pathological site
The necessity of a large total dose of a drug
Non-specific toxicity and other adverse side-effects.
isnt there any solution
2
-
7/31/2019 Fahad Drug Targeting
3/24
DRUG TARGETING
Targeted drug delivery is a method of delivering medication to a
patient in a manner that increases the concentration of themedication in some parts of the body relative to others.
Objective Provide therapeutic concentration of drugs at the site of
action Reduce systemic toxicity Increase patient compliance
This improves efficacy of the drug while reducing sideeffects.
3
-
7/31/2019 Fahad Drug Targeting
4/24
ADVANTAGESOF DRUG TARGETING
Drug administration protocols may be simplified.
Drug quantity required to achieve a therapeutic effect may be
greatly reduced as well as the cost of therapy.
Drug concentration in the required sites can be sharply
increased without negative effects on non-target
compartments.
4
-
7/31/2019 Fahad Drug Targeting
5/24
CLASSIFICATIONOF DRUG TARGETINGDrug targeting has been classified into three types:
First Order
It refers to restricted distribution of the drug-carrier system to the capillarybed of a predetermined target site, organ or tissue. Compartmentaltargeting in lymphatics*, peritoneal cavity, cerebral ventricles, lungs,
joints, eyes, etc.
Second Order
The selective delivery of drugs to a specific cell type such as tumor cellsand not to the normal cells is referred as second order drug targeting.The selective drug delivery to the Kupffer cells in the liver** exemplifiesthis approach.
Third OrderThe third order targeting is defined as drug delivery specifically to the
intracellular site of target cells. The receptor based ligand-mediatedentry of drug complex into a cell by endocytosis, lysosomal degradationof carrier followed by release of drug intra-cellularly or gene delivery tonucleolus is an example for this approach.
* A network of vessels that conveys electrolytes, water, proteins, etc in the form of lymph from the tissue fluids to the bloodstream.
** Phagocytic cells that line the sinusoids of the liver
5
-
7/31/2019 Fahad Drug Targeting
6/24
Drug Targeting
Passive Targeting Active targeting
Direct local application
Tumor microenvironment
Leaky Vasculature
Antibody targeted
Carbohydrate targeted
Receptor targeted
6
-
7/31/2019 Fahad Drug Targeting
7/24
DRUG TARGETING
Principal schemes of drug targeting currently investigated in various
experimental and clinical settings include: Direct application of the drug into the affected zone (organ, tissue)
Passive accumulation of the drug through leaky vasculature (tumors,infarcts, inflammation)
physical targeting based on abnormal pH and / or temperature in thetarget zone, such as tumor or inflammation (pH- and temperature-sensitive drug carriers)
Magnetic targeting of drugs attached to paramagnetic carriers under the
action of external magnetic field
Use of vector molecules possessing high specific affinity toward theaffected zone
7
-
7/31/2019 Fahad Drug Targeting
8/24
DRUG TARGETING
The parameters determining the efficacy of drug targeting:
Size of the target
Blood flow through the target
Number of binding sites for the targeted drug/ drugcarrier within the target
Number and affinity of targeting moieties
8
-
7/31/2019 Fahad Drug Targeting
9/24
PASSIVETARGETINGAPPROACHES
Take advantage of natural anatomical structures or physiological processes,
which direct carrier in vivo distribution
Pathophysiological factors Inflammation, Infection, EPR effect
Physicochemical factors Size, Molecular weight
Anatomical opportunities Catheterization, Direct injection
Chemical approaches Prodrugs, Chemical delivery systems
Fig: Spontaneous drug accumulation in `leaky' areas
9
-
7/31/2019 Fahad Drug Targeting
10/24
ACTIVETARGETINGAPPROACHES
Carrier specificity can be enhanced, through surfacefunctionalization with site-directed ligands which bind or interactwith specific tissues
Biochemical targets Organs, Cellular, Organelles, Intracellular
Physical/External Stimuli Ultrasound, Magnetic field10
-
7/31/2019 Fahad Drug Targeting
11/24
MAIN APPROACHESTO TARGETING
Retrometabolic Systems: Individual drug molecules chemically modified to target
particularly to the disease site.
Carrier Based Systems:
Drug is first packaged non-covalently into a syntheticCarrier that is then targeted to the disease site.
11
-
7/31/2019 Fahad Drug Targeting
12/24
DRUG TARGETING: PRODRUGS
Compounds that undergo biotransformation prior toexhibiting pharmacological effect
12
-
7/31/2019 Fahad Drug Targeting
13/24
PRODRUG CONTINUING: OVERCOMING BARRIERS
Chemically linking pro-moiety to form prodrug
Biotransformation
Release of parent drug
Barrier is circumvented
Examples:
6-Monoacetylmorphine (6-MAM) is a heroin metabolite which convertsinto active morphine in vivo.
Prednisone, a synthetic cortico-steroid drug, is bioactivated by the liverinto the active drug prednisolone.
13
-
7/31/2019 Fahad Drug Targeting
14/24
DRUG TARGETING: MAGNETIC DRUG TARGETING
14
The Biophysical Targeting Technique
Using magnetic nanoparticles (ferrofluids) Enhancing efficacy
Minimum side effects Ferromagnetic element (e.g. an implant) is placed in amagnetic field, it becomes magnetically energized
-
7/31/2019 Fahad Drug Targeting
15/24
-
7/31/2019 Fahad Drug Targeting
16/24
Solid tumor
Apply magneticfield to concentrateparticles
Modulate field torelease drug fromparticles
Inject NMPs IV,NMP will circulate
through the blood stream
Other options:1 - Direct injection intotumor site2 - Coating NMP with
antibodies to target
MAGNETIC DRUG TARGETING CONTINUING: GUIDED DRUG DELIVERY
Ability to addlocalized heatingcombined with drugdelivery
-
7/31/2019 Fahad Drug Targeting
17/24
MAGNETIC DRUG TARGETING CONTINUING: ADVANTAGES
Magnetic drug targeting is used to treat malignant tumors loco-regionally without systemic toxicity.
Magnetic particles used as carrier system for a variety ofanticancer agents, e.g. radionuclides, cancer specificantibodies, and genes
17
-
7/31/2019 Fahad Drug Targeting
18/24
DRUG TARGETING: LIPOSOMES
18
These are vesicular concentric structures, range in size from a nanometer to several
micrometers, containing a phospholipids bilayer and are biocompatible, biodegradableand non immunogenic.
Liposomes have generated a great interest because of their versatility andhave played a significant role in formulation of potent drugs to improvetherapeutics. Enhanced safety and efficacy have been achieved for a widerange of drug classes, including antitumor agents, antiviral, antimicrobials,vaccines, gene therapeutics etc.
-
7/31/2019 Fahad Drug Targeting
19/24
TWO-STEPS
TARGETING
Specificallybinding to
tumor cellBind
chromosomalDNA in target
tumor cell
http://www.bms.uu.se/twostep/intercalate.htmhttp://www.bms.uu.se/twostep/intercalate.htmhttp://www.bms.uu.se/twostep/intercalate.htmhttp://www.bms.uu.se/twostep/intercalate.htmhttp://www.bms.uu.se/twostep/intercalate.htmhttp://www.bms.uu.se/twostep/intercalate.htmhttp://www.bms.uu.se/twostep/intercalate.htmhttp://www.bms.uu.se/twostep/intercalate.htm -
7/31/2019 Fahad Drug Targeting
20/24
DRUG TARGETING: TRANSDERMAL APPROACH
Transdermal drug delivery system is topically administered
medicaments in the form of patches that deliver drugs forsystemic effects at a predetermined and controlled rate.
A transdermal drug delivery device, which may be of an active ora passive design, is a device which provides an alternative routefor administering medication. These devices allow forpharmaceuticals to be delivered across the skin barrier.
20
-
7/31/2019 Fahad Drug Targeting
21/24
TRANSDERMAL APPROACH CONTINUING:
In theory, transdermal patches work very simply. A drug is applied in arelatively high dosage to the inside of a patch, which is worn on the
skin for an extended period of time. Through a diffusion process, thedrug enters the bloodstream directly through the skin.
Since there is high concentration on the patch and low concentration inthe blood, the drug will keep diffusing into the blood for a long periodof time, maintaining the constant concentration of drug in the bloodflow. 21
-
7/31/2019 Fahad Drug Targeting
22/24
DRUG TARGETING: BRAINTARGETEDDRUGDELIVERYSYSTEM
The brain is a delicate organ, and evolution built very efficient ways to protect it. The
delivery of drugs to central nervous system (CNS) is a challenge in the treatment ofneurological disorders.
Drugs may be administered directly into the CNS or administered systematically (e.g., byintravenous injection) for targeted action in the CNS. The major challenge to CNSdrug delivery is the blood-brain barrier (BBB), which limits the access of drugs to thebrain substance.
Fig: Central Nervous System-selective Estrogens: A Safe Estrogen Therapy
22
-
7/31/2019 Fahad Drug Targeting
23/24
BRAINTARGETEDDRUGDELIVERYSYSTEM CONTINUING:
Advances in understanding of the cell biology of the BBB haveopened new avenues and possibilities for improved drug delivery tothe CNS.
Various strategies that have been used for manipulating the blood-
brain barrier for drug delivery to the brain include osmotic andchemical opening of the blood-brain barrier as well as the use oftransport/carrier systems.
Other strategies for drug delivery to the brain involve bypassing theBBB. Various pharmacological agents have been used to open the
BBB and direct invasive methods can introduce therapeutic agentsinto the brain substance.
23
-
7/31/2019 Fahad Drug Targeting
24/24
CONCLUSION
Research related to the development of targeted drug delivery systemis now a day is highly preferred and facilitating field of pharmaceuticalworld. It has crossed the infancy period and now touching height ofgrowths from the pharmacy point of view.
Targeted delivery of drugs, as the name suggests, is to assist the drugmolecule to reach preferably to the desired site. The inherentadvantage of this technique has been the reduction in dose & sideeffect of the drug.
Overall it may be concluded with the vast database of different studies,the science of site specific or targeted delivery of these drugs hasbecome wiser. Manifestation of these strategies in clinical now seemspossible in near future.
24